4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid has been researched along with alitretinoin in 1 studies
| Studies (4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid) | Trials (4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid) | Recent Studies (post-2010) (4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid) | Studies (alitretinoin) | Trials (alitretinoin) | Recent Studies (post-2010) (alitretinoin) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 854 | 47 | 269 |
| Protein | Taxonomy | 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid (IC50) | alitretinoin (IC50) |
|---|---|---|---|
| retinoic acid receptor alpha isoform 1 | Homo sapiens (human) | 0.0084 | |
| retinoic acid receptor RXR-alpha isoform a | Homo sapiens (human) | 0.0189 | |
| Retinoic acid receptor alpha | Homo sapiens (human) | 0.007 | |
| Retinoic acid receptor beta | Homo sapiens (human) | 0.007 | |
| Retinoic acid receptor alpha | Mus musculus (house mouse) | 0.031 | |
| Retinoic acid receptor gamma | Homo sapiens (human) | 0.017 | |
| Retinoic acid receptor RXR-alpha | Homo sapiens (human) | 0.0305 | |
| Retinoic acid receptor RXR-alpha | Mus musculus (house mouse) | 0.082 | |
| Retinoic acid receptor RXR-beta | Homo sapiens (human) | 0.012 | |
| Retinoic acid receptor RXR-gamma | Homo sapiens (human) | 0.004 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blomhoff, HK; Blomhoff, R; Dawson, MI; Gandhi, U; Lømo, J; Natarajan, V; Smeland, EB; Ulven, S | 1 |
1 other study(ies) available for 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid and alitretinoin
| Article | Year |
|---|---|
RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes.
Topics: Alitretinoin; Apoptosis; B-Lymphocytes; CD40 Antigens; CD40 Ligand; DNA; DNA-Binding Proteins; Gene Expression; Humans; Immunoglobulin M; Interleukin-4; Ligands; Lymphocyte Activation; Membrane Glycoproteins; Receptors, Retinoic Acid; Retinoid X Receptors; Retinoids; Transcription Factors; Transcription, Genetic; Transfection; Tretinoin | 1998 |